Abstract
Short-acting beta agonist (SABA) overuse (≥3 canisters annually) is associated with worse asthma outcomes and accounts for the majority of greenhouse gas emissions from asthma inhalers in England. Reducing SABA...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have